Eye 更正:Aflibercept 8 mg 用于新生血管性年龄相关性黄斑变性和糖尿病性黄斑水肿——将临床试验转化为临床实践
Correction: Aflibercept 8 mg in neovascular age-related macular degeneration and diabetic macular oedema: Translating clinical trials into clinical practice
《Eye》发布更正,涉及 Aflibercept 8 mg 用于新生血管性年龄相关性黄斑变性和糖尿病性黄斑水肿、将临床试验转化为临床实践的论文。更正了正文、参考文献、资助及利益冲突部分中的笔误,原文已更正。
Correction to: Eye https://doi.org/10.1038/s41433-026-04779-5, published online 07 August 2026
In this article typos in text, references, funding and competing interest section have been corrected.


The original article has been corrected.
Author information
Authors and Affiliations
NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, UK
Sobha Sivaprasad
Department of Ophthalmology, Mayo Clinic, Jacksonville, FL, USA
Michael W. Stewart
Retina Consultants of Texas, Retina Consultants of America, Houston, TX, USA
Charles C. Wykoff
Retina Vitreous Associates of Florida, Saint Petersburg, FL, USA
David Eichenbaum
Morsani College of Medicine at the University of South Florida, Tampa, FL, USA
David Eichenbaum
CHU Bordeaux, Service d’Ophtalmologie, Bordeaux, France
Jean-Francois Korobelnik
University of Bordeaux, INSERM, BPH, UMR1219, Bordeaux, France
Jean-Francois Korobelnik
Department of Medicine-Ophthalmology, University of Udine, Udine, Italy
Paolo Lanzetta
Istituto Europeo di Microchirurgia Oculare-IEMO, Udine, Italy
Paolo Lanzetta
Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada
Varun Chaudhary
Division of Ophthalmology, Department of Surgery, McMaster University, Hamilton, ON, Canada
Varun Chaudhary
Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore
Chui Ming Gemmy Cheung & Tien Yin Wong
Duke-National University of Singapore Medical School, Singapore, Singapore
Chui Ming Gemmy Cheung & Tien Yin Wong
Hull York Medical School, University of York, York, UK
Richard Gale
Hull York Medical School, University of York, and York and Scarborough Teaching Hospitals NHS Foundation Trust, York, UK
Richard Gale
Gutblick Practise Group, Pfäffikon, Switzerland
Marion R. Munk
Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
Marion R. Munk
Department of Ophthalmology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
Marion R. Munk
Department of Ophthalmology, Kagoshima University, Kagoshima, Japan
Taiji Sakamoto
Department of Ophthalmology, University Medicine Greifswald, Mecklenburg-Vorpommern, Greifswald, Germany
Andreas Stahl
Hospital Clínic de Barcelona, Barcelona, Spain
Javier Zarranz-Ventura
Department of Surgery and Medical-Surgical Specialties, Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain
Javier Zarranz-Ventura
Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
Javier Zarranz-Ventura
Beijing Visual Science and Translational Eye Research Institute (BERI), Beijing Tsinghua Changgung Hospital, Beijing, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, China
Tien Yin Wong
School of Biomedical Engineering, Tsinghua Medicine, Tsinghua University, Beijing, China
Tien Yin Wong
Department of Ophthalmology and GRADE Reading Center, University of Bonn, Bonn, Germany
Frank G. Holz
Department of Ophthalmology, Tel Aviv Medical Centre, Tel Aviv, Israel
Anat Loewenstein
Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel
Anat Loewenstein
Authors
- Sobha Sivaprasad
- Michael W. Stewart
- Charles C. Wykoff
- David Eichenbaum
- Jean-Francois Korobelnik
- Paolo Lanzetta
- Varun Chaudhary
- Chui Ming Gemmy Cheung
- Richard Gale
- Marion R. Munk
- Taiji Sakamoto
- Andreas Stahl
- Javier Zarranz-Ventura
- Tien Yin Wong
- Frank G. Holz
- Anat Loewenstein
Corresponding author
Correspondence to Anat Loewenstein.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Sivaprasad, S., Stewart, M.W., Wykoff, C.C. et al. Correction: Aflibercept 8 mg in neovascular age-related macular degeneration and diabetic macular oedema: Translating clinical trials into clinical practice. Eye (2026). https://doi.org/10.1038/s41433-026-04887-2
Published: 20 October 2026
Version of record: 20 October 2026
DOI: https://doi.org/10.1038/s41433-026-04887-2
来源:Nature 健康护理主题 · nature.com